Carlo M. Croce
Carlo Maria Croce (born December 17, 1944) is an Italian-American professor of medicine at Ohio State University, specializing in oncology and the molecular mechanisms underlying cancer. Croce and his research have attracted public attention because of multiple allegations of scientific misconduct. Provided by Wikipedia
Showing 1 - 14 results of 14 for search 'Carlo M. Croce', query time: 0.03s
Refine Results
-
1
MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies by Taewan Kim, Carlo M. Croce
Published 2023-07-01
Article -
2
Small Non-Coding RNAs in Leukemia by Veronica Balatti, Carlo M. Croce
Published 2022-01-01
Article -
3
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review by Marilena V Iorio, Carlo M Croce
Published 2017-06-01
Article -
4
-
5
Detecting and Characterizing A-To-I microRNA Editing in Cancer by Gioacchino P. Marceca, Luisa Tomasello, Rosario Distefano, Mario Acunzo, Carlo M. Croce, Giovanni Nigita
Published 2021-04-01
Article -
6
-
7
-
8
tRFUniverse: A comprehensive resource for the interactive analyses of tRNA-derived ncRNAs in human cancer by Alessandro La Ferlita, Salvatore Alaimo, Giovanni Nigita, Rosario Distefano, Joal D. Beane, Philip N. Tsichlis, Alfredo Ferro, Carlo M. Croce, Alfredo Pulvirenti
Published 2024-02-01
Article -
9
Transcriptome Analysis of Human Endogenous Retroviruses at Locus-Specific Resolution in Non-Small Cell Lung Cancer by Alessandro La Ferlita, Rosario Distefano, Salvatore Alaimo, Joal D. Beane, Alfredo Ferro, Carlo M. Croce, Philip N. Tsichlis, Alfredo Pulvirenti, Giovanni Nigita
Published 2022-09-01
Article -
10
In situ hybridization to detect DNA amplification in extracellular vesicles by Lucia Casadei, Patricia Sarchet, Fernanda Costas C. deFaria, Federica Calore, Giovanni Nigita, Sayumi Tahara, Luciano Cascione, Martin Wabitsch, Francis J. Hornicek, Valerie Grignol, Carlo M. Croce, Raphael E. Pollock
Published 2022-09-01
Article -
11
NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs by Tyler Sheetz, Joseph Mills, Anna Tessari, Megan Pawlikowski, Ashley E. Braddom, Tasha Posid, Debra L. Zynger, Cindy James, Valerio Embrione, Kareesma Parbhoo, Claudia Foray, Vincenzo Coppola, Carlo M. Croce, Dario Palmieri
Published 2020-07-01
Article -
12
Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel. by Eugenio Gaudio, Francesco Paduano, Riccardo Spizzo, Apollinaire Ngankeu, Nicola Zanesi, Marco Gaspari, Francesco Ortuso, Francesca Lovat, Jonathan Rock, Grace A Hill, Mohamed Kaou, Giovanni Cuda, Rami I Aqeilan, Stefano Alcaro, Carlo M Croce, Francesco Trapasso
Published 2013-01-01
Article -
13
HNRNPL Restrains <i>miR-155</i> Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia by Sara Pagotto, Angelo Veronese, Alessandra Soranno, Veronica Balatti, Alice Ramassone, Paolo E. Guanciali-Franchi, Giandomenico Palka, Idanna Innocenti, Francesco Autore, Laura Z. Rassenti, Thomas J. Kipps, Renato Mariani-Costantini, Luca Laurenti, Carlo M. Croce, Rosa Visone
Published 2019-04-01
Article -
14
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma by Gian Luca Rampioni Vinciguerra, Marina Capece, Luca Reggiani Bonetti, Giovanni Nigita, Federica Calore, Sydney Rentsch, Paolo Magistri, Roberto Ballarin, Fabrizio Di Benedetto, Rosario Distefano, Roberto Cirombella, Andrea Vecchione, Barbara Belletti, Gustavo Baldassarre, Francesca Lovat, Carlo M. Croce
Published 2024-02-01
Article